Adjuvants in Infant Immunization: Advances and Challenges in Vaccine Development

Infant immunization is a cornerstone of global public health, providing protection against life-threatening infectious diseases. However, the immature immune system of infants often results in suboptimal vaccine responses. Adjuvants are critical components of vaccines, enhancing immunogenicity and shaping immune responses to ensure effective and long-lasting protection. This review explores recent advancements in adjuvant technologies, their mechanisms of action, and their role in improving vaccine efficacy in infants. Additionally, we discuss the challenges associated with adjuvant use, including safety concerns, regulatory hurdles, and the need for precision-designed adjuvants that balance efficacy with minimal adverse effects. Ongoing research in novel adjuvant formulations, such as toll-like receptor (TLR) agonists, saponin-based adjuvants, and nanoparticle-based delivery systems, offers promising directions for optimizing infant immunization. Understanding the evolving landscape of adjuvant development is essential for designing next-generation vaccines that provide robust and durable immunity in early life. Keywords: Infant immunization, Vaccine adjuvants, Immunogenicity enhancement, Novel adjuvant formulations, Next-generation vaccines